Abraham Scaria

The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells

Ann E. Tollefson, Abraham Scaria, Terry Hermiston et al. · Journal of Virology · 1996 · 374 citations · Full text

Viral Replication, Viral Pathogenesis, Immunology +16

CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10

Guo-Xiang Ruan, Elizabeth Barry, Dan Yu et al. · Molecular Therapy · 2017 · 266 citations · Full text

Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains.

Darlene Barr, Julie Tubb, Deron Ferguson et al. · PubMed · 1995 · 238 citations

The E3-11.6-kDa Adenovirus Death Protein (ADP) Is Required for Efficient Cell Death: Characterization of Cells Infected withadpMutants

Ann E. Tollefson, Jan S. Ryerse, Abraham Scaria et al. · Virology · 1996 · 225 citations

Apoptosis, Viral Pathogenesis, Immunology +8

Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial

Jeffrey S. Heier, Saleema Kherani, Shilpa J. Desai et al. · The Lancet · 2017 · 220 citations

Open-label Trial, Translational Medicine, Ocular Disease +8